Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Lu Li Analyst Performance

Analyst at UBS Group

Lu Li is a stock analyst at UBS Group in the medical sector, covering 5 publicly traded companies. Over the past year, Lu Li has issued 14 stock ratings, including buy and hold recommendations. While full access to Lu Li's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lu Li's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
16 Last 1 Years
Buy Recommendations
33.33% 5 Buy Ratings
Companies Covered
5 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy33.3%5 ratings
Hold66.7%10 ratings
Sell0.0%0 ratings

Out of 15 total stock ratings issued by Lu Li at UBS Group, the majority (66.7%) have been Hold recommendations, followed by 33.3% Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
80.0% of companies on NASDAQ
4 companies
NYSE
20.0% of companies on NYSE
1 company

Lu Li, an analyst at UBS Group, currently covers 5 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
100.0%

Lu Li of UBS Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
2 companies
40.0%
MED PRODUCTS
1 company
20.0%
MED - BIOMED/GENE
1 company
20.0%
MEDICAL INFO SYS
1 company
20.0%

Lu Li's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
5/7/2026Reiterated Rating$10.77$12.00Neutral
Waters Corporation stock logo
WAT
Waters
5/6/2026Boost Price Target$352.53$375.00Neutral
Veracyte, Inc. stock logo
VCYT
Veracyte
5/6/2026Boost Price Target$39.42$52.00Buy
Waters Corporation stock logo
WAT
Waters
4/13/2026Lower Price Target$324.34$330.00Neutral
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
4/10/2026Lower Price Target$13.97$17.00Neutral
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
2/24/2026Lower Price Target$4.38$6.00Neutral
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
2/12/2026Set Price Target$21.71$30.00
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1/21/2026Boost Price Target$32.73$35.00Neutral
Veracyte, Inc. stock logo
VCYT
Veracyte
1/12/2026Reiterated Rating$43.51Buy
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
11/6/2025Boost Price Target$22.60$31.00Neutral
Veracyte, Inc. stock logo
VCYT
Veracyte
11/5/2025Boost Price Target$44.97$48.00Buy
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
11/4/2025Boost Price Target$8.18$8.00Neutral
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
8/7/2025Lower Price Target$23.95$26.00Neutral
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
8/5/2025Upgrade$18.36$30.00Buy
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
5/8/2025Lower Price Target$36.59$29.00Neutral
Veracyte, Inc. stock logo
VCYT
Veracyte
5/8/2025Lower Price Target$31.51$42.00Buy